|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 21 of 22 found articles
| Title: |
SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11) |
| Author: |
Retz, Margitta Bedke, Jens Bögemann, Martin Grimm, Marc-Oliver Zimmermann, Uwe Müller, Lothar Leiber, Christian Teber, Dogu Wirth, Manfred Bolenz, Christian van Alphen, Robbert De Santis, Maria Beeker, Aart Lehmann, Jan Indorf, Martin Frank, Melanie Bokemeyer, Carsten Gschwend, Jürgen E. |
| Appeared in: |
European journal of cancer |
| Paging: | Volume 107 (2019) nr. C pages 37-45 |
| Year: |
2019 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 21 of 22 found articles
| << previous | next >> |